One of the principal loci involved in the regulation of the actions of lutropin/choriogonadotropin (LH/CG) is the LH/CG receptor (LH/CG-R). The regulation that occurs at this level can be due to an attenuation of the ability of a constant number of receptors to activate the effector system (uncoupling) or to a decrease in the actual number of receptors (down-regulation). Uncoupling and/or down-regulation of the LH/CG-R can be elicited not only by LH/CG, but also by other hormones that do not bind to the LH/CG-R (such as epidermal growth factor) and by some second messengers such as phorbol esters and cAMP analogues. Although it may appear as if down-regulation and uncoupling are redundant (given that they are elicited by the same stimuli), their different time courses suggest that their relative importance in the overall refractoriness of the cell may vary in a temporal fashion. The studies proposed herein seek to understand the molecular basis of the regulation of the actions of LH/CG that occur at the level of the LH/CG-R. Using clonal strains of cultured Leydig tumor cells that express functional LH/CG-Rs, and novel clonal cell lines obtained by permanent transfection with the wild type or mutated forms of the LH/CG-R cDNA we propose to (1) identify post-translational modifications of the LH/CG-R that are responsible for uncoupling the receptor from Gs; (2) determine if the rapid rate of endocytosis of LH/CG requires the interaction of the LH/CG-R with Gs; and (3) characterize the transcriptional regulation of the LH/CG-R gene in MA- 10 Leydig tumor cells. A complete understanding of the regulation of hormone action is a major aspect of the field of endocrinology. Since the LH/CG-R is a member of the growing family of G-protein coupled receptors, our data will provide important information not only about the regulation of the actions of LH/CG, but also about the mechanisms involved in the regulation of the numbers and functional activity of this important family of receptors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA040629-11
Application #
2090293
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1992-02-22
Project End
1998-01-31
Budget Start
1994-02-01
Budget End
1995-01-31
Support Year
11
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Iowa
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Matzkin, Maria Eugenia; Yamashita, Soichi; Ascoli, Mario (2013) The ERK1/2 pathway regulates testosterone synthesis by coordinately regulating the expression of steroidogenic genes in Leydig cells. Mol Cell Endocrinol 370:130-7
Tai, Ping; Ascoli, Mario (2011) Reactive oxygen species (ROS) play a critical role in the cAMP-induced activation of Ras and the phosphorylation of ERK1/2 in Leydig cells. Mol Endocrinol 25:885-93
Yamashita, Soichi; Tai, Ping; Charron, Jean et al. (2011) The Leydig cell MEK/ERK pathway is critical for maintaining a functional population of adult Leydig cells and for fertility. Mol Endocrinol 25:1211-22
Tai, Ping; Shiraishi, Koji; Ascoli, Mario (2009) Activation of the lutropin/choriogonadotropin receptor inhibits apoptosis of immature Leydig cells in primary culture. Endocrinology 150:3766-73
Galet, Colette; Ascoli, Mario (2008) Arrestin-3 is essential for the activation of Fyn by the luteinizing hormone receptor (LHR) in MA-10 cells. Cell Signal 20:1822-9
Shiraishi, Koji; Ascoli, Mario (2008) A co-culture system reveals the involvement of intercellular pathways as mediators of the lutropin receptor (LHR)-stimulated ERK1/2 phosphorylation in Leydig cells. Exp Cell Res 314:25-37
Shiraishi, Koji; Ascoli, Mario (2007) Lutropin/choriogonadotropin stimulate the proliferation of primary cultures of rat Leydig cells through a pathway that involves activation of the extracellularly regulated kinase 1/2 cascade. Endocrinology 148:3214-25
Ascoli, Mario (2007) Potential Leydig cell mitogenic signals generated by the wild-type and constitutively active mutants of the lutropin/choriogonadotropin receptor (LHR). Mol Cell Endocrinol 260-262:244-8
Galet, Colette; Ascoli, Mario (2006) A constitutively active mutant of the human lutropin receptor (hLHR-L457R) escapes lysosomal targeting and degradation. Mol Endocrinol 20:2931-45
Shiraishi, Koji; Ascoli, Mario (2006) Activation of the lutropin/choriogonadotropin receptor in MA-10 cells stimulates tyrosine kinase cascades that activate ras and the extracellular signal regulated kinases (ERK1/2). Endocrinology 147:3419-27

Showing the most recent 10 out of 47 publications